Bevacizumab/steroids/thalidomideLack of efficacy and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1933卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28071-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：120 / 120

相关论文

共 50 条

[41] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2024, 2036 (1) : 314 - 314
[42] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1981 (1) : 270 - 270
[43] Furosemide/remdesivirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1954 (1) : 219 - 219
[44] Immunosuppressants/molnupiravirLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1943 (1) : 362 - 362
[45] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1838 (1) : 56 - 56
[46] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1885 (1) : 357 - 357
[47] Multiple drugsLack of efficacy and off label use: case report
Reactions Weekly, 2023, 1963 (1) : 373 - 373
[48] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[49] AcetylcysteineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1900 (1) : 16 - 16
[50] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81

← 1 2 3 4 5 →